Healthcare provider profile · identity verified

Jeffrey Dennis Kueter, MD

Family Practice · PLATTEVILLE, WI · NPI 1154317295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	191	67
Omeprazole	Omeprazole	132	38
Levothyroxine Sodium	Levothyroxine Sodium	114	33
Lisinopril	Lisinopril	110	38
Amlodipine Besylate	Amlodipine Besylate	98	37
Rosuvastatin Calcium	Rosuvastatin Calcium	95	30
Losartan Potassium	Losartan Potassium	81	28
Escitalopram Oxalate	Escitalopram Oxalate	77	17
Metoprolol Succinate	Metoprolol Succinate	77	29
Tamsulosin Hcl	Tamsulosin Hcl	74	23
Pantoprazole Sodium	Pantoprazole Sodium	68	27
Fluticasone Propionate	Fluticasone Propionate	66	31
Metformin Hcl	Metformin Hcl	64	24
Simvastatin	Simvastatin	62	18
Furosemide	Furosemide	59	25
Gabapentin	Gabapentin	52	23
Potassium Chloride	Potassium Chloride	50	17
Hydrochlorothiazide	Hydrochlorothiazide	48	18
Metformin Hcl Er	Metformin Hcl	48	17
Jardiance	Empagliflozin	47	14
Allopurinol	Allopurinol	44	11
Prednisone	Prednisone	43	29
Sertraline Hcl	Sertraline Hcl	42	suppressed
Xarelto	Rivaroxaban	41	suppressed
Trazodone Hcl	Trazodone Hcl	37	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	11
Spironolactone	Spironolactone	36	11
Carvedilol	Carvedilol	32	11
Lorazepam	Lorazepam	32	12
Atenolol	Atenolol	30	suppressed
Cephalexin	Cephalexin	30	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Naproxen	Naproxen	28	14
Bupropion Xl	Bupropion Hcl	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	11
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Albuterol Sulfate Hfa	Albuterol Sulfate	26	19
Glipizide Er	Glipizide	24	suppressed
Finasteride	Finasteride	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Mupirocin	Mupirocin	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Pregabalin	Pregabalin	21	11
Verapamil Er	Verapamil Hcl	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	13
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Diazepam	Diazepam	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Mounjaro	Tirzepatide	17	suppressed
Nystatin	Nystatin	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Azithromycin	Azithromycin	16	14
Clonazepam	Clonazepam	16	suppressed
Eliquis	Apixaban	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Duloxetine Hcl	Duloxetine Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Baclofen	Baclofen	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error